Related Experiment Video
Updated: May 21, 2026
22:02
Gene Transfer to the Developing Mouse Inner Ear by In Vivo Electroporation
Published on: June 30, 2012
Gene transfer in inner ear cells: a challenging race
R Sacheli1, L Delacroix, P Vandenackerveken
1GIGA-Neurosciences, Developmental Neurobiology Unit, University of Liège, Liège, Belgium.
Gene Therapy
|June 29, 2012
Summary
Gene therapies offer new hope for treating deafness by targeting defective genes. Advances in gene transfer technologies are crucial for developing effective treatments for sensorineural hearing loss.
Area of Science:
- Genomics
- Otolaryngology
- Molecular Biology
Background:
- Human genomics has identified genes linked to deafness, presenting new therapeutic targets.
- Gene-based treatments for sensorineural hearing loss are emerging, including gene therapy and antisense delivery.
Purpose of the Study:
- To review advancements in inner ear gene transfer technologies.
- To discuss strategies for gene-based treatments of hearing disorders.
Main Methods:
- Review of recent literature on viral and non-viral gene delivery to the mammalian inner ear.
- Analysis of factors influencing transgene expression, including vector type, administration route, and promoter strength.
Main Results:
- Gene transfer into the inner ear has been established using various vectors.
- The efficacy of gene transfer depends on cell targeting, expression levels, and duration.
Conclusions:
- Effective gene carrier systems are essential for developing gene therapies for deafness.
- Understanding gene transfer dynamics is key to advancing treatments for inner ear disorders.
